[1] Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani

[2] Roles of endogenous gamma interferon and macrophage microbicidal mechanisms in host response to chemotherapy in experimental visceral leishmaniasis

[3] Clinical and experimental advances in treatment of visceral leishmaniasis

[4] Interleukin-12 regulates the response to chemotherapy in experimental visceral Leishmaniasis

[5] Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani

[6] IL-10 mediates susceptibility to Leishmania donovani infection

[7] IL-12 gene-deficient C57BL/6 mice are susceptible to Leishmania donovani but have diminished hepatic immunopathology

[8] Early enhanced Th1 response after Leishmania amazonensis infection of C57BL/6 interleukin-10-deficient mice does not lead to resolution of infection

[9] The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure

[10] Targeting malaria and leishmaniasis: Synthesis and pharmacological evaluation of novel pyrazole-1,3,4-oxadiazole hybrids. Part II

[11] Risk of establishment of canine leishmaniasis infection through the import of dogs into South Africa

[12] Exploring global and country-level barriers to an effective supply of leishmaniasis medicines and diagnostics in eastern Africa: a qualitative study.

[13] Effectiveness of Single-Dose Liposomal Amphotericin B in Visceral Leishmaniasis in Bihar.

[14] The usefulness of trained field workers in diagnosis of post-kala-Azar dermal leishmaniasis (PKDL) and clinico-epidemiological profile in highly endemic areas of Bihar

[15] Insecticide susceptibility status of Phlebotomus argentipes, a vector of visceral leishmaniasis in different foci in three states of India

[16] Meta-taxonomic analysis of prokaryotic and eukaryotic gut flora in stool samples from visceral leishmaniasis cases and endemic controls in Bihar State India.

[17] In vitro antiprotozoal activity of some medicinal plants against sleeping sickness, Chagas disease and leishmaniasis.

[18] A review of visceral leishmaniasis during the conflict in South Sudan and the consequences for East African countries.

[19] Socioeconomic and behavioural risk factors for infection of visceral leishmaniasis gedaref state – Sudan 2015

[20] American cutaneous leishmaniasis in French Guiana: an epidemiological update and study of environmental risk factors.

[21] Disseminated Autochthonous Dermal Leishmaniasis Caused by (PCM2 Trang) in a Patient from Central Thailand Infected with Human Immunodeficiency Virus.

[22] Prone Regions of Zoonotic Cutaneous Leishmaniasis in Southwest of Iran: Combination of Hierarchical Decision Model (AHP) and GIS.

[23] An epidemiological study of visceral leishmaniasis in North East Ethiopia using serological and leishmanin skin tests.

[24] Potential Use of Interleukin-10 Blockade as a Therapeutic Strategy in Human Cutaneous Leishmaniasis.

[25] High resolution melting based method for rapid discriminatory diagnosis of co-infecting Leptomonas seymouri in Leishmania donovani-induced leishmaniasis.

[26] Publisher Correction: Leishmania RNA virus exacerbates Leishmaniasis by subverting innate immunity via TLR3-mediated NLRP3 inflammasome inhibition (Nature Communications, (2019), 10, 1, (5273), 10.1038/s41467-019-13356-2)

[27] The use of cold atmospheric plasma in pentostam enhancement as Leishmaniasis treatment in vitro

[28] Emergence of cutaneous leishmaniasis in a border area at south-east of Iran: an epidemiological survey

[29] Patients' preferences of cutaneous leishmaniasis treatment outcomes: Findings from an international qualitative study.

[30] Surveillance for Leishmania asymptomatic infection in endemic foci of cutaneous leishmaniasis in Venezuela: a combination of leishmanin skin test and PCR using blood clots improves detection and enables identification of species.

[31] Test accuracy of polymerase chain reaction methods against conventional diagnostic techniques for Cutaneous Leishmaniasis (CL) in patients with clinical or epidemiological suspicion of CL: Systematic review and meta-analysis.

[32] Leishmania sp. detection and blood-feeding behaviour of Sergentomyia minuta collected in the human leishmaniasis focus of southwestern Madrid, Spain (2012-2017).

[33] [Pediatric cutaneous leishmaniasis in Morocco: Clinical and epidemiological features].

[34] Genomes of Leishmania parasites directly sequenced from patients with visceral leishmaniasis in the Indian subcontinent.

[35] [Epidemiology of Cutaneous Leishmaniasis in Algeria through Molecular Characterization].

[36] Isolation and Molecular Typing of from in a Re-Emerging Focus of Leishmaniasis, Northeastern Italy.

[37] Species diversity and molecular insights into phlebotomine sand flies in Sardinia (Italy)-an endemic region for leishmaniasis.

[38] Molecular Analysis of Gene in Non-Healing Clinical Isolates Obtained from Patients with Cutaneous Leishmaniasis from Central of Iran.

[39] Geospatial analysis of tegumentary leishmaniasis in Rio de Janeiro state, Brazil from 2000 to 2015: Species typing and flow of travelers and migrants with leishmaniasis.

[40] Autochthonous canine visceral leishmaniasis cases occur in Paraná state since 2012: isolation and identification of Leishmania infantum.

[41] Serological and molecular investigation of Leishmania spp. infection in cats from an area endemic for canine and human leishmaniasis in Northeast Brazil.

[42] Association of Phlebotomus guggisbergi with Leishmania major and Leishmania tropica in a complex transmission setting for cutaneous leishmaniasis in Gilgil, Nakuru county, Kenya.

[43] Molecular epidemiology and in vitro evidence suggest that Leishmania braziliensis strain helps determine antimony response among American tegumenary leishmaniasis patients

[44] Epidemiology of cutaneous leishmaniasis in Algeria by molecular characterization

[45] Spatiotemporal and molecular epidemiology of cutaneous leishmaniasis in Libya

[46] Molecular epidemiology of human cutaneous leishmaniasis in Jericho and its vicinity in Palestine from 1994 to 2015

[47] Molecular epidemiology of imported cases of leishmaniasis in Australia from 2008 to 2014

[48] Molecular epidemiology of cutaneous leishmaniasis and heterogeneity of Leishmania major strains in Iran

[49] Molecular epidemiology for vector research on leishmaniasis

[50] Molecular epidemiology of American tegumentary Leishmaniasis in Panama

[51] Molecular epidemiology of leishmaniasis in Asia (focus on cutaneous infections)

[52] Antigen genes for molecular epidemiology of leishmaniasis: Polymorphism of cysteine proteinase B and surface metalloprotease glycoprotein 63 in the Leishmania donovani complex

[53] The epidemiology of visceral leishmaniasis in East Africa: Hints and molecular revelations

[54] Molecular epidemiology of cutaneous Leishmaniasis in Venezuela

[55] Leishmania mini-exon genes for molecular epidemiology of leishmaniasis in China and Ecuador

[56] International Workshop on Molecular Epidemiology. Proposals of the Interdisciplinary Group on American Trypanosomiasis and Leishmaniasis

[57] Molecular approaches applied to the epidemiology of leishmaniasis in Venezuela.

[58] Cutaneous Leishmaniasis Due to Leishmania aethiopica

[59] Detection of Leishmania spp in silvatic mammals and isolation of Leishmania (Viannia) braziliensis from Rattus rattus in an endemic area for leishmaniasis in Minas Gerais State, Brazil.

[60] Zoonotic cutaneous leishmaniasis in Shiraz, Southern Iran: A molecular, isoenzyme and morphologic approach

[61] Imported leishmaniasis cases in Cuba (2006–2016): what have we learned

[62] Epidemiological Aspects of Visceral Leishmaniasis in Baft District, Kerman Province, Southeast of Iran

[63] Old World cutaneous leishmaniasis treatment response varies depending on parasite species, geographical location and development of secondary infection

[64] Possible introduction of to urban areas determined by epidemiological and clinical profiles of patients with cutaneous leishmaniasis in Casablanca (Morocco).

[65] The enemy at home: leishmaniasis in the Mediterranean basin, Italy on the focus.

[66] Characterization of visceral leishmaniasis outbreak, Marsabit County, Kenya, 2014.

[67] Changes in the Epidemiology of Cutaneous Leishmaniasis in Northeastern Iran

[68] A spotlight on the diagnostic methods of a fatal disease Visceral Leishmaniasis.

[69] Phenotypical Characterization of Spleen Remodeling in Murine Experimental Visceral Leishmaniasis.

[70] A cross-sectional approach including dog owner characteristics as predictors of visceral leishmaniasis infection in dogs.

[71] The preclinical discovery and development of oral miltefosine for the treatment of visceral leishmaniasis: a case history.

[72] Pathological roles of MRP14 in anemia and splenomegaly during experimental visceral leishmaniasis.

[73] Expression of a rK39 homologue from an Iranian Leishmania infantum isolate in Leishmania tarentolae for serodiagnosis of visceral leishmaniasis.

[74] Transcriptome Analysis Identifies Immune Markers Related to Visceral Leishmaniasis Establishment in the Experimental Model of BALB/c Mice.

[75] Estimation of Biological Parameters of Cutaneous Ulcers Caused by Leishmaniasis in an Animal Model Using Diffuse Reflectance Spectroscopy.

[76] Visceral Leishmaniasis in West Africa: Clinical Characteristics, Vectors, and Reservoirs.

[77] Psychosocial impact of scars due to cutaneous leishmaniasis on high school students in Errachidia province, Morocco

[78] Knowledge, attitudes and practices related to visceral leishmaniasis in rural communities of Amhara State: a longitudinal study in northwest Ethiopia.

[79] Determinants of Response to Interleukin-10 Receptor Blockade Immunotherapy in Experimental Visceral Leishmaniasis

[80] Visceral leishmaniasis infection in a refractory multiple myeloma patient treated with bortezomib

[81] phlebotomine sand flies (diptera, psychodidae) in an american tegumentary leishmaniasis transmission area in northern espírito santo state, brazil fauna de flebotomíneos (diptera, psychodidae) em área de transmissão de leishmaniose tegumentar americana no norte do estado do espírito santo, brasil

[82] high performance of an enzyme linked immunosorbent assay for american tegumentary leishmaniasis diagnosis with leishmania (viannia) braziliensis amastigotes membrane crude antigens.

[83] aspectos ecológicos da leishmaniose tegumentar americana: 8. avaliação da atividade enzoótica de leishmania (viannia) braziliensis, em ambiente florestal e peridomiciliar, região do vale do ribeira, estado de são paulo, brasil ecological aspects of american cutaneous leishmaniasis: 8. assessment on enzootic activity of leishmania (v.) braziliensis, in forest and peridomicile environments of the ribeira valley region, são paulo state, brazil

[84] acute erythroid toxicity in visceral leishmaniasis: a rare complication of antimonial therapy

[85] cytokine profile in montenegro skin test of patients with localized cutaneous and mucocutaneous leishmaniasis perfil de citocinas na intradermorreação de montenegro em doentes de leishmaniose cutânea localizada e cutâneo-mucosa

[86] il-23 and il-27 levels in macrophages collected from peripheral blood of patients with healing vs non-healing form of cutaneous leishmaniasis

[87] sand fly species composition (diptera: psychodidae: phlebotominae) in the municipality of cantagalo , an area with sporadic cases of human cutaneous leishmaniasis in rio de janeiro state, brazil

[88] linfocitos t citotóxicos cd8+ en la leishmaniasis cutánea cd8+ cytotoxic lymphocytes in cutaneous leishmaniasis

[89] hepatic granulomas in canine visceral leishmaniasis and clinical status granulomas hepáticos na leishmaniose visceral canina e classificação clínica

[90] description of six autochthonous cases of canine visceral leishmaniasis diagnosed in pedregulho (são paulo, brazil)

[91] community knowledge, attitude and practice towards cutaneous leishmaniasis endemic area ochello, gamo gofa zone, south ethiopia

[92] associated-risk determinants for anthroponotic cutaneous leishmaniasis treated with meglumine antimoniate: a cohort study in iran.

[93] topical treatment modalities for old world cutaneous leishmaniasis: a review

[94] efficiency of noninvasive sampling methods (swab) together with polymerase chain reaction (pcr) for diagnosing american tegumentary leishmaniasis

[95] serological survey for canine cutaneous and visceral leishmaniasis in areas at risk for transmission in rio de janeiro where prophylatic measures had been adopted

[96] canine leishmaniasis surveillance program in a san marino republic kennel

[97] detection and identification of leishmania isolates from patients with cutaneous leishmaniasis (cl) in isfahan (central region of iran) by pcr method

[98] the effect of education based on the theory of planned behavior on preventive behaviors of cutaneous leishmaniasis in mothers living in endemic city of natanz

[99] comparison the efficacy of ablative co 2 laser and fractional co 2 laser on the healing of cutaneous leishmaniasis scars

[100] interpretation of electrocardiographic, echocardiographic and biochemical findings during different stages of canine visceral leishmaniasis

[101] avaliação de três esquemas terapêuticos com o antimoniato de n-metil-glucamina no tratamento da leishmaniose visceral no estado do pará, brasil evaluation of three chemotherapeutic schemes with meglumine antimoniate in the treatment of visceral leishmaniasis in the state of pará, brazil